Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | RXRA | P19793 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5275886 | 1.00 | POLB (0.48) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL4204560 | 1.00 | POLB (0.48) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL4881266 | 0.93 | ALDH1A1 (0.50) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL4447455 | 0.93 | ALDH1A1 (0.50) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL23076115 | 0.89 | POLB (0.55) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL328973 | 0.85 | POLB (0.57) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL328974 | 0.85 | POLB (0.57) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL3087847 | 0.85 | MEN1 (0.60) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL3960853 | 0.85 | MEN1 (0.60) | POLBCNR2CNR1ALDH1A1MAPT | |
| SCHEMBL21226235 | 0.80 | SMN1; SMN2 (0.59) | POLBALDH1A1MAPTHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2348014-B1 | Unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions | INT FLAVORS & FRAGRANCES INC (US) | 2017-05-10 | — | — | EP | claimed |
| US-9144248-B2 | Cinnamamides as savory flavorings | SYMRISE AG (DE) | 2015-09-29 | — | — | US | claimed |
| EP-2529632-B1 | Cinnamic acid amides as spicy flavour agents | SYMRISE AG (DE) | 2013-08-28 | — | — | EP | claimed |
| US-20120308703-A1 | Cinnamamides as savory flavorings | SYMRISE AG (DE) | 2012-12-06 | — | — | US | claimed |
| EP-2529632-A1 | Cinnamic acid amides as spicy flavour agents | Symrise AG (DE) | 2012-12-05 | — | — | EP | claimed |
| US-20260114489-A1 | DRY PARTICLE COATING TO PRODUCE STABLE POWDERS | GIVAUDAN SA (CH) | 2026-04-30 | — | — | US | disclosed |
| EP-3911172-B1 | COMBINATION OF SATIETY COMPONENTS WITH ARGININE | SYMRISE AG (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-20260014103-A1 | COMBINATION REMEDY | SYMRISE AG (DE) | 2026-01-15 | — | — | US | disclosed |
| EP-3823455-B1 | COMPOSITION FOR SUBSTITUTING SUGAR IN BAKED GOODS | SYMRISE AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| US-20250297266-A1 | METHODS FOR GENE AMPLIFICATION | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-09-25 | — | — | US | disclosed |
| EP-3806661-B1 | USE OF ANTAGONISTS OF T2R54 | FIRMENICH INCORPORATED (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4566459-A2 | ANTAGONISTS OF T2R54 AND COMPOSITIONS AND USES THEREOF | Firmenich Incorporated (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20100080880-A1 | GERANYLAMINE DERIVATES OF OXALIC ACID | SYMRISE GMBH & CO. KG (DE) | 2010-04-01 | — | — | US | disclosed |
| US-20100080880-A1 | GERANYLAMINE DERIVATES OF OXALIC ACID | SYMRISE GMBH & CO. KG (DE) | 2010-04-01 | — | — | US | disclosed |
| EP-2168442-A2 | Geranylamine derivatives of oxalic acid | Symrise GmbH & Co. KG (DE) | 2010-03-31 | — | — | EP | disclosed |
| US-20090311402-A1 | ALKYLDIENAMIDES EXHIBITING TASTE AND SENSORY EFFECT IN FLAVOR COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-12-17 | — | — | US | disclosed |
| US-20090311402-A1 | ALKYLDIENAMIDES EXHIBITING TASTE AND SENSORY EFFECT IN FLAVOR COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-12-17 | — | — | US | disclosed |
| US-7632531-B2 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | International Flavors & Fragnances Inc. (US) | 2009-12-15 | — | — | US | disclosed |
| US-7632531-B2 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | International Flavors & Fragnances Inc. (US) | 2009-12-15 | — | — | US | disclosed |
| US-20080038386-A1 | Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition | MOZA ASHOK K | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100080880-A1 | GERANYLAMINE DERIVATES OF OXALIC ACID | OTC, OAT, ODC1 | POLB 1988/4885CNR2 3221/4885CNR1 3807/4885 |
| US-20260014103-A1 | COMBINATION REMEDY | TAS2R43, TAS2R41, TAS2R60 | POLB 4830/4885CNR2 1633/4885CNR1 2043/4885 |
| US-20090311402-A1 | ALKYLDIENAMIDES EXHIBITING TASTE AND SENSORY EFFECT IN FLAVOR COMPOSITIONS | TAS2R5, TAS2R45, TAS2R16 | POLB 3507/4885CNR2 523/4885CNR1 410/4885 |
| US-20260114489-A1 | DRY PARTICLE COATING TO PRODUCE STABLE POWDERS | LIPA, DAGLA, SCD | POLB 4464/4885CNR2 1833/4885CNR1 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.